WATNYSELaboratory Analytical InstrumentsFiscal year ends December 31
WATERS CORP /DE/
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Aug 11, 2026
$434.27−2.68 (-0.61%)
Close on Oct 19, 2026
- Market cap
- $42.65T
- P/E (TTM)
- 108.3
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
100.0%
99M of 98M shares
Institutional holders
1,177
158 new, 135 sold out
Net institutional buying
6M
In Q2 2026
Insider trades, 12 months
2 buys · 1 sales
Net sold $991.86K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 7,637,586 | 7.80% | 13G (passive) amendment | Mar 31, 2026 |
| Vanguard Capital Management | 7,351,785 | 7.49% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of WAT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8,484,939 | 8.64% | $3.18B | −58,075 | 0.05% |
| Vanguard Capital Management LLC | 6,415,552 | 6.53% | $2.41B | +36,777 | 0.05% |
| Vanguard Portfolio Management LLC | 4,740,524 | 4.83% | $1.78B | −13,661 | 0.08% |
| Massachusetts Financial Services Co /Ma/ | 4,625,035 | 4.71% | $2.53B | −5,083 | 0.80% |
| State Street Corp | 4,382,008 | 4.46% | $1.64B | +19,998 | 0.05% |
| T. Rowe Price Investment Management, Inc. | 3,817,779 | 3.89% | $1.43M | −846,100 | 0.94% |
| Invesco Ltd. | 3,494,267 | 3.56% | $1.31B | +1,325,982 | 0.10% |
| Alliancebernstein L.P. | 2,694,590 | 2.74% | $802.45M | +577,853 | 0.27% |
| First Eagle Investment Management, LLC | 2,670,216 | 2.72% | $1.00B | +1,095,029 | 0.83% |
| Geode Capital Management, LLC | 2,636,146 | 2.68% | $984.75M | −10,312 | 0.05% |
| Fundsmith LLP | 2,273,632 | 2.31% | $852.70M | −938,443 | 6.25% |
| Price T Rowe Associates Inc /Md/ | 2,177,958 | 2.22% | $816.82K | +1,053,930 | 0.08% |
| JPMorgan Chase & Co | 2,158,391 | 2.20% | $796.17M | +184,743 | 0.04% |
| Jupiter Topco LLC | 1,663,601 | 1.69% | $623.92M | New | 0.25% |
| Viking Global Investors LP | 1,662,140 | 1.69% | $623.37M | +405,678 | 1.78% |
| Wellington Management Group Llp | 1,373,150 | 1.40% | $514.99M | +561,824 | 0.09% |
| Schroder Investment Management Group | 1,264,226 | 1.29% | $474.14M | +948,023 | 0.34% |
| Mawer Investment Management Ltd. | 1,216,947 | 1.24% | $456.40M | −186,680 | 3.10% |
| Principal Financial Group Inc | 1,114,092 | 1.13% | $417.84M | +94,803 | 0.21% |
| Morgan Stanley | 1,097,302 | 1.12% | $411.53M | −124,612 | 0.02% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1,177 | 99M | 100.0% | 158 / 355 | 476 / 135 | 14M | 8M |
| Q1 2026 | 1,176 | 95M | 96.6% | 464 / 573 | 111 / 84 | 48M | 4M |
| Q4 2025 | 808 | 58M | 59.4% | 131 / 247 | 289 / 67 | 6M | 6M |
| Q3 2025 | 756 | 58M | 58.7% | 95 / 231 | 303 / 98 | 8M | 9M |
| Q2 2025 | 771 | 59M | 59.8% | 82 / 275 | 278 / 66 | 4M | 3M |
| Q1 2025 | 765 | 58M | 59.0% | 76 / 282 | 270 / 61 | 4M | 3M |
| Q4 2024 | 761 | 57M | 58.4% | 131 / 269 | 233 / 53 | 4M | 4M |
| Q3 2024 | 696 | 57M | 57.9% | 76 / 236 | 247 / 67 | 8M | 3M |
| Q2 2024 | 694 | 57M | 58.2% | 76 / 252 | 225 / 64 | 3M | 5M |
| Q1 2024 | 688 | 60M | 60.9% | 74 / 191 | 274 / 55 | 3M | 3M |
| Q4 2023 | 673 | 60M | 60.9% | 92 / 213 | 252 / 58 | 6M | 3M |
| Q3 2023 | 650 | 57M | 58.3% | 70 / 215 | 233 / 61 | 4M | 3M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of WAT | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3,116,340 | 3.17% | $1.17B | 0.05% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 2,545,419 | 2.59% | $954.63M | 0.06% | Jun 30, 2026 |
| Vanguard Mid-Cap Index Fund | 2,127,547 | 2.17% | $797.92M | 0.36% | Jun 30, 2026 |
| T. Rowe Price Capital Appreciation Fund | 2,101,625 | 2.14% | $788.19M | 1.12% | Jun 30, 2026 |
| iShares Core S&P 500 ETF | 1,350,484 | 1.37% | $506.49M | 0.06% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 1,255,093 | 1.28% | $481.42M | 0.06% | May 31, 2026 |
| Janus Henderson Enterprise Fund | 1,170,078 | 1.19% | $438.83M | 1.96% | Jun 30, 2026 |
| Vanguard Mid-Cap Growth Index Fund | 752,232 | 0.77% | $282.12M | 0.81% | Jun 30, 2026 |
| MidCap Fund | 745,494 | 0.76% | $281.28M | 1.22% | Jul 31, 2026 |
| First Eagle Global Fund | 699,700 | 0.71% | $264.00M | 0.35% | Jul 31, 2026 |
| Vanguard Growth Index Fund | 697,108 | 0.71% | $261.44M | 0.07% | Jun 30, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF | 693,612 | 0.71% | $260.13M | 0.64% | Jun 30, 2026 |
| MFS International Intrinsic Value Fund | 639,930 | 0.65% | $245.46M | 0.98% | May 31, 2026 |
| Allspring Special Mid Cap Value Fund | 617,300 | 0.63% | $231.51M | 1.72% | Jun 30, 2026 |
| MFS Massachusetts Investors Growth Stock Fund | 567,372 | 0.58% | $217.63M | 2.36% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Udit Batra | President and CEO, Director | 33,140 | 0.03% | Mar 3, 2026 |
| Tong (NMN) Wu | SVP Waters Analytical Sciences | – | – | Aug 31, 2026 |
| Robert L. Carpio III | SVP Waters Analytical Sciences | 3,426 | 0.00% | Jun 25, 2026 |
| Amol Chaubal | SVP & Chief Financial Officer | 7,835 | 0.01% | May 14, 2026 |
| Jianqing Bennett | SVP Waters Adv. Diagnostics | 6,532 | 0.01% | Apr 7, 2026 |
| Christopher A. Kuebler | Director | 17,808 | 0.02% | Aug 7, 2026 |
| Heather Knight | Director | 1,281 | 0.00% | Jul 2, 2026 |
| Wei Jiang | Director | 3,573 | 0.00% | Jul 2, 2026 |
| Richard H. Fearon | Director | 3,302 | 0.00% | Mar 10, 2026 |
| Linda Baddour | Director | 2,899 | 0.00% | Feb 27, 2026 |
| Flemming Ornskov | Director | 5,271 | 0.01% | Feb 27, 2026 |
| Claire Fraser | Director | 489 | 0.00% | Feb 27, 2026 |
| Pearl S. Huang | Director | 3,276 | 0.00% | Feb 27, 2026 |
| Daniel J. Brennan | Director | 1,355 | 0.00% | Feb 27, 2026 |
| Mark Vergnano | Director | 4,540 | 0.00% | Feb 27, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Christopher A. Kuebler Director | Aug 6, 2026 | Sale | −3,626 | $397.94 | $1.44M | 17,808 |
| Christopher A. Kuebler Director | Aug 6, 2026 | Option exercise | +3,626 | $136.43 | $494.70K | 21,434 |
| Wei Jiang Director | Jun 30, 2026 | Award | +67.42 | – | – | 3,573 |
| Heather Knight Director | Jun 30, 2026 | Award | +63.03 | – | – | 1,281 |
| Robert L. Carpio III SVP Waters Analytical Sciences | Jun 24, 2026 | Tax withholding | −189 | $369.18 | $69.78K | 3,426 |
| Amol Chaubal SVP & Chief Financial Officer | May 12, 2026 | Tax withholding | −239 | $352.21 | $84.18K | 7,623 |
| Jianqing Bennett SVP Waters Adv. Diagnostics | Apr 6, 2026 | Tax withholding | −302 | $304.09 | $91.84K | 6,532 |
| Heather Knight Director | Mar 31, 2026 | Award | +68.44 | – | – | 1,218 |
| Wei Jiang Director | Mar 31, 2026 | Award | +64.06 | – | – | 3,505 |
| Wei Jiang Director | Mar 16, 2026 | Buy | +500 | $289.46 | $144.73K | 3,441 |
| Richard H. Fearon Director | Mar 6, 2026 | Buy | +1,000 | $306.34 | $306.34K | 3,302 |
| Udit Batra President and CEO, Director | Mar 2, 2026 | Tax withholding | −3,417 | $307.23 | $1.05M | 33,140 |
| Amol Chaubal SVP & Chief Financial Officer | Mar 2, 2026 | Tax withholding | −709 | $307.23 | $217.83K | 7,796 |
| Jianqing Bennett SVP Waters Adv. Diagnostics | Mar 2, 2026 | Tax withholding | −410 | $307.23 | $125.96K | 6,834 |
| Pearl S. Huang Director | Feb 25, 2026 | Award | +23 | – | – | 3,276 |
| Udit Batra President and CEO, Director | Feb 25, 2026 | Award | +5,165 | – | – | 36,557 |
| Amol Chaubal SVP & Chief Financial Officer | Feb 25, 2026 | Award | +1,455 | – | – | 8,505 |
| Jianqing Bennett SVP Waters Adv. Diagnostics | Feb 25, 2026 | Award | +986 | – | – | 7,244 |
| Flemming Ornskov Director | Feb 25, 2026 | Award | +336 | – | – | 5,271 |
| Mark Vergnano Director | Feb 25, 2026 | Award | +23 | – | – | 4,540 |
| Christopher A. Kuebler Director | Feb 25, 2026 | Award | +23 | – | – | 17,808 |
| Linda Baddour Director | Feb 25, 2026 | Award | +23 | – | – | 2,899 |
| Daniel J. Brennan Director | Feb 25, 2026 | Award | +23 | – | – | 1,355 |
| Robert L. Carpio III SVP Waters Analytical Sciences | Feb 25, 2026 | Award | +997 | – | – | 3,615 |
| Claire Fraser Director | Feb 25, 2026 | Award | +358 | – | – | 489 |
| Richard H. Fearon Director | Feb 25, 2026 | Award | +23 | – | – | 2,302 |
| Heather Knight Director | Feb 25, 2026 | Award | +23 | – | – | 1,149 |
| Wei Jiang Director | Feb 25, 2026 | Award | +23 | – | – | 2,941 |
| Jianqing Bennett SVP TA Instruments Division | Feb 5, 2026 | Tax withholding | −43 | $376.89 | $16.21K | 6,258 |
| Udit Batra President and CEO, Director | Feb 5, 2026 | Tax withholding | −218 | $376.89 | $82.16K | 31,392 |
| Robert L. Carpio III SVP, Waters Division | Feb 5, 2026 | Tax withholding | −38 | $376.89 | $14.32K | 2,618 |
| Amol Chaubal SVP & Chief Financial Officer | Feb 5, 2026 | Tax withholding | −58 | $376.89 | $21.86K | 7,050 |
| Jianqing Bennett SVP TA Instruments Division | Feb 4, 2026 | Award | +1,385 | – | – | 6,301 |
| Udit Batra President and CEO, Director | Feb 4, 2026 | Award | +7,066 | – | – | 31,610 |
| Amol Chaubal SVP & Chief Financial Officer | Feb 4, 2026 | Award | +1,884 | – | – | 7,108 |
| Mark Vergnano Director | Jan 2, 2026 | Award | +307 | – | – | 4,517 |
| Pearl S. Huang Director | Jan 2, 2026 | Award | +307 | – | – | 3,253 |
| Daniel J. Brennan Director | Jan 2, 2026 | Award | +307 | – | – | 1,332 |
| Richard H. Fearon Director | Jan 2, 2026 | Award | +307 | – | – | 2,279 |
| Flemming Ornskov Director | Jan 2, 2026 | Award | +307 | – | – | 4,935 |
| Linda Baddour Director | Jan 2, 2026 | Award | +307 | – | – | 2,876 |
| Wei Jiang Director | Jan 2, 2026 | Award | +307 | – | – | 2,918 |
| Christopher A. Kuebler Director | Jan 2, 2026 | Award | +307 | – | – | 17,785 |
| Heather Knight Director | Jan 2, 2026 | Award | +307 | – | – | 1,126 |
| Wei Jiang Director | Dec 31, 2025 | Award | +59.79 | – | – | 2,611 |
| Heather Knight Director | Dec 31, 2025 | Award | +59.79 | – | – | 819 |
| Christopher A. Kuebler Director | Nov 5, 2025 | Option exercise | +3,761 | $130.35 | $490.25K | 18,796 |
| Christopher A. Kuebler Director | Nov 5, 2025 | Tax withholding | −1,318 | $371.97 | $490.26K | 17,478 |
| Wei Jiang Director | Sep 30, 2025 | Award | +72.91 | – | – | 2,551 |
| Heather Knight Director | Sep 30, 2025 | Award | +77.88 | – | – | 759 |
| Wei Jiang Director | Jun 30, 2025 | Award | +68.35 | – | – | 2,479 |
| Heather Knight Director | Jun 30, 2025 | Award | +68.35 | – | – | 681 |
| Robert L. Carpio III SVP, Waters Division | Jun 24, 2025 | Tax withholding | −134 | $346.80 | $46.47K | 2,656 |
| Amol Chaubal SVP & Chief Financial Officer | May 12, 2025 | Tax withholding | −239 | $366.67 | $87.63K | 5,224 |
| Jianqing Bennett SVP TA Instruments Division | Apr 7, 2025 | Tax withholding | −303 | $325.80 | $98.72K | 4,916 |
| Wei Jiang Director | Mar 31, 2025 | Award | +52.95 | – | – | 2,410 |
| Heather Knight Director | Mar 31, 2025 | Award | +52.95 | – | – | 613 |
| Jianqing Bennett SVP TA Instruments Division | Mar 1, 2025 | Tax withholding | −786 | $371.79 | $292.23K | 5,219 |
| Amol Chaubal SVP & Chief Financial Officer | Mar 1, 2025 | Tax withholding | −1,076 | $371.79 | $400.05K | 5,369 |
| Udit Batra President and CEO, Director | Mar 1, 2025 | Tax withholding | −4,976 | $371.79 | $1.85M | 24,544 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Christopher A. Kuebler Director | Aug 6, 2026 | 3,626 | $1.44M | Aug 6, 2026 | Stock Option Exercise |
| Christopher A. Kuebler Director | May 15, 2024 | 4,000 | $1.45M | May 15, 2024 | Option Granted - 01/02/2015 |
| Linda Baddour Director | Mar 13, 2024 | 500 | $177.77K | Mar 13, 2024 | Restricted Stock Vesting |
| Jonathan M. Pratt Former Officer | Dec 15, 2023 | 2,116 | $678.76K | Dec 15, 2023 | Option Granted - 05/03/2021 |
| Jonathan M. Pratt Former Officer | Dec 8, 2023 | 2,158 | $632.95K | Dec 8, 2023 | Option Granted - 02/18/2021 |
| Jonathan M. Pratt Former Officer | Nov 15, 2023 | 8,758 | $2.34M | Nov 15, 2023 | Option Granted - 10/10/2019 |
| Christopher A. Kuebler Director | Aug 4, 2023 | 4,000 | $1.17M | Aug 4, 2023 | Option Granted 01/02/2014 |